Multiple sclerosis treatment using cell therapy

Application of suspensions containing fetal stem cells in patients with multiple sclerosis (also known as "disseminated sclerosis" or "encephalomyelitis disseminata") gives positive results in all forms and stages of this disease. Unique Cell Treatment Clinic has developed and successfully applies its own method of multiple sclerosis treatment with the use of stem cells. The mechanism of action of this treatment is very simple: by restoring the immune system competency, fetal stem cells stop the autoimmune reaction of destroying one's own myelin proteins, thus making it possible to achieve a stable and long-term remission. Influenced by various factors they proliferate and differentiate into neural tissue. This allows the body of the person to minimize the clinical manifestations of the demyelination process, to improve the dynamics of neurological functions recovery, significantly improve the quality of life.

Stem cell therapy allows to achieve the successful results in curing of people with relapsing-remitting form of encephalomyelitis disseminata (in 90% of the cases a stable remission is achieved, that lasts 2-2.5 times longer than usual). Multiple sclerosis treatment of persons with other types of this disease reaches a stable remission in 55% of the cases. Effects of our recovery remain for many years. Our patients report absence of disease progression, preservation of working capacity, improved quality of life. Typically, people who apply to us undergo repeated courses of healing of this disease at intervals of 1.5-2 years.

Effects of recovery from multiple sclerosis through cell injections provided by our clinic

Administration of fetal stem cell suspension in patients with multiple sclerosis, as a rule, leads to immediate improvement of psycho-emotional condition of the person, while neurological effects need some longer period of time to develop. As a result of multiple sclerosis treatment more than 90% of the patients show syndrome of the early posttransplantation improvements, which manifests in improved mood and appetite, appearance of vivacity, decreased weakness. Moreover, 63% of the patients observe deep psychosomatic changes: decreased depression, anxieties about future, phobias. They are more confident in their recovery, have improved working capacity and better ability to concentrate their attention (it helps, for example, in achieving better results in professional and learning activities).

During the very first year after stem cell treatment, many UCTC patients improve eyesight, eliminate their depression, improve mental abilities and emotional sphere. Motor disturbances and speech disorder, disturbances of gastrointestinal tract and pelvic organs dysfunction can be treated as well, however this requires a lot more time. About 72% of patients must repeat the curing of multiple sclerosis once per year. Those with multiple sclerosis’ primary progressive forms now report that the disease stops progressing in 3-6 months right after the stem cell treatment. It is important to keep in mind that the nervous system reconstruction is a quite long process that requires not only time, but also patience. Along with Parkinson’s disease and Diabetes Mellitus, Multiple Sclerosis refers to the type of diseases that can be treated with administration of fetal stem cells. 

Multiple Sclerosis, along with Parkinsons disease and diabetes mellitus, refers to such diseases, in treatment of which administration of fetal stem cells is effective and allows achieving positive results.

The course of Multiple Sclerosis treatment at the UCTC takes, as a rule, 2 days.